Jump to content

Günter Ollenschläger

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Glewe (talk | contribs) at 15:16, 13 March 2020 (External links). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Guenter Ollenschlaeger, 2008

Günter Ollenschläger (born 3 March 1951 in Bonn) is a German physician, medical editor, and professor of internal medicine and clinical decision making at the University of Cologne, Faculty of Medicine.

Biography

Ollenschläger is a certified pharmacist and general internist. He has a pharmaceutical doctorate from the University of Münster (1977), a medical doctorate from the University of Giessen (1982), and the venia legendi from the University of Cologne (1990).

Günter Ollenschläger worked as a research pharmacist from 1975 until 1981, and as a university physician from 1983 until 1990, working in the fields of pharmacokinetics, tumor related malnutrition,[1] and metabolism.

Ollenschläger joined the German Medical Association as director of Continuing Medical Education from 1990 until 1995. From 1995 until 2014 he was founding head of the German Agency for Quality in Medicine. In that capacity he introduced a variety of projects to develop evidence based healthcare and knowledge management as well as patient safety in German healthcare:

Ollenschläger was co-founder of the German Network for Evidence Based Medicine in 1998,[9] and of the German Coalition for Patient Safety in 2005. He was co-founder and Founding Chairman of the Guidelines International Network in 2002.[10]

He was chief editor of the German Journal for Evidence and Quality in Healthcare ZEFQ from 1995 until 2015.

From 2015 until 2016 Günter Ollenschläger was editor-in-chief of the medical encyclopedia DEXIMED, the German version of the Norwegian e-book NEL.[11]

Awards

References

  1. ^ Ollenschläger G, Thomas W, Konkol K, Diehl V, Roth E: Nutritional behaviour and quality of life during oncological polychemotherapy: Results of a prospective study on the efficacy of oral nutrition therapy in patients with acute leukemia. Eur J Clin Invest 1992; 22: 546-553
  2. ^ Ollenschläger, G.; Kirchner, H.; Oesingmann, U.; Kolkmann, F. W.; Kunz, R. (2001). "The German Guidelines Clearing house (GGC) – rationale, aims and results" (PDF). Proceedings of the Royal College of Physicians of Edinburgh. 31 (Supplement 9): 59–64.
  3. ^ Sänger, S; Nickel, J; Huth, A; Ollenschläger, G (2002). "Gut informiert über Gesundheitsfragen, aber wie? - Das Deutsche Clearingverfahren für Patienteninformationen - Zielsetzung, Hintergrund und Arbeitsweise" [Well-informed on health matters--how well? The German 'Clearinghouse for Patient Information'--objective, background and methods]. Das Gesundheitswesen (in German). 64 (7): 391–7. doi:10.1055/s-2002-32812. PMID 12119584.
  4. ^ Delbanco, T; Berwick, DM; Boufford, JI; Edgman-Levitan, S; Ollenschläger, G; Plamping, D; Rockefeller, RG (2001). "Healthcare in a land called PeoplePower: nothing about me without me". Health Expectations. 4 (3): 144–50. doi:10.1046/j.1369-6513.2001.00145.x. PMC 5060064. PMID 11493320.
  5. ^ Ollenschläger, Günter; Kopp, Ina (2007). "Nationale VersorgungsLeitlinien von BÄK, AWMF und KBV" [The German program for disease management guidelines. Results and perspectives]. Medizinische Klinik (in German). 102 (5): 383–7. doi:10.1007/s00063-007-1052-1. PMID 17497089.
  6. ^ Weinbrenner, Susanne; Conrad, Susann; Weikert, Beate; Kopp, Ina (2010). "7 Jahre Nationale VersorgungsLeitlinien (NVL) - Quo vadis?" [After seven years of National Disease Management Guidelines: quo vadis?]. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen (in German). 104 (7): 533–9. doi:10.1016/j.zefq.2010.07.010. PMID 21095605.
  7. ^ Schaefer, Corinna; Kirschning, Silke (2010). "Gut informiert entscheiden: Patienten- und Verbraucherinformationen am ÄZQ" [Informed decisions: patient and consumer information at the German Agency for Quality in Medicine (ÄZQ)]. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen (in German). 104 (7): 578–84. doi:10.1016/j.zefq.2010.09.001. PMID 21095611.
  8. ^ Ollenschläger, G. (2001), "Medizinische Risiken, Fehler und Patientensicherheit. Zur Situation in Deutschland" (PDF), Schweizerische Ärztezeitung (in German), 82 (26): 1404–10, doi:10.4414/saez.2001.08273, archived from the original (PDF) on 2012-03-22
  9. ^ DNEbM Office. History of the German Network for Evidence based Medicine,Berlin 2007
  10. ^ G. Ollenschläger, C. Marshall, S. Qureshi et al.: Improving the quality of health care: using international collaboration to inform guideline programmes by founding the Guidelines International Network (G-I-N). Qual Saf Health Care 2004;13:455-460
  11. ^ Norsk Helseinformatikk: NEL - The German editorial team
  12. ^ Guidelines International Network: Honorary Patron 2005
  13. ^ German Network for Evidence based Medicine : Honorary Chairman 2013
  14. ^ Honorary Membership German Network for Evidence Based Medicine 2016